Latent autoimmune diabetes in adults (LADA) should be less latent
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Pugliese, A., Zeller, M., Fernandez, A., Zalcberg, L. J., Bartlett, R. J., Ricordi, C., Pietropaolo, M., Eisenbarth, G. S., Bennett, S. T., & Patel, D. D. (1997) · Nature Genetics · doi:10.1038/ng0397-293 · Cited by 945 · cited 1×
“It is hypothesised [25, 26] that IDDM2 regulates the expression of proinsulin in the thymus and thereby the selection of proinsulin-reactive T cells and the acquisition of immune tolerance to proinsulin.”
BackgroundEffect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus
Vafiadis, P., Bennett, S. T., Todd, J. A., Nadeau, J., Grabs, R., Goodyer, C. G., Wickramasinghe, S., Colle, E., & Polychronakos, C. (1997) · Nature Genetics · doi:10.1038/ng0397-289 · Cited by 809 · cited 1×
“It is hypothesised [25, 26] that IDDM2 regulates the expression of proinsulin in the thymus and thereby the selection of proinsulin-reactive T cells and the acquisition of immune tolerance to proinsulin.”
BackgroundTurner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay, I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03062-6 · Cited by 779 · cited 4×
“The minimum age cut-off for LADA varies from 25 to 40 years [5, 10, 12], but is arbitrary.”
BackgroundInfluentialBennett, S. T., Lucassen, A. M., Gough, S. C. L., Powell, E. E., Undlien, D. E., Pritchard, L. E., Merriman, M. E., Kawaguchi, Y., Dronsfield, M. J., Pociot, F., et al. (1995) · Nature Genetics · doi:10.1038/ng0395-284 · Cited by 746 · cited 1×
“Short class I VNTR alleles predispose to type 1 diabetes, whereas longer class III alleles are protective [24].”
BackgroundTuomi, T., Groop, L. C., Zimmet, P. Z., Rowley, M. J., Knowles, W., & Mackay, I. R. (1993) · Diabetes · doi:10.2337/diab.42.2.359 · Cited by 581
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-7-199804010-00001 · Cited by 546
Cited by
Epidemiology of type 1 diabetes
Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.011 · Cited by 1,092
The many faces of diabetes: a disease with increasing heterogeneity
Tuomi, T., Santoro, N., Caprio, S., Cai, M., Weng, J., & Groop, L. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62219-9 · Cited by 652
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype
Hawa, M. I., Kolb, H., Schloot, N., Beyan, H., Paschou, S. A., Buzzetti, R., Mauricio, D., De Leiva, A., Yderstraede, K., Beck-Neilsen, H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0931 · Cited by 339
The Emerging Global Epidemic of Type 1 Diabetes
Tuomilehto, J. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0433-5 · Cited by 292
Clinical Applications of Diabetes Antibody Testing
Bingley, P. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1365 · Cited by 278
“A recent Cochrane Review suggested that there was “some evidence that sulfonylurea may bring about earlier insulin dependence,” but this was based in part on examination of published survival curves of these UKPDS data showing rates of progression of about 42 vs. 30% at 10 yr without apparent statistical analysis and…”
BackgroundInfluentialAdult-onset autoimmune diabetes: current knowledge and implications for management
Buzzetti, R., Zampetti, S., & Maddaloni, E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.99 · Cited by 271
Zhou, Z., Xiang, Y., Ji, L., Jia, W., Ning, G., Huang, G., Yang, L., Lin, J., Liu, Z., Hagopian, W. A., et al. (2013) · Diabetes · doi:10.2337/db12-0207 · Cited by 251
Latent Autoimmune Diabetes in Adults
Naik, R. G., Brooks-Worrell, B. M., & Palmer, J. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1120 · Cited by 249
Self-citationBuzzetti, R., Di Pietro, S., Giaccari, A., Petrone, A., Locatelli, M., Suraci, C., Capizzi, M., Arpi, M. L., Bazzigaluppi, E., Dotta, F., et al. (2007) · Diabetes Care · doi:10.2337/dc06-1696 · Cited by 242
Self-citationFourlanos, S., Varney, M. D., Tait, B. D., Morahan, G., Honeyman, M. C., Colman, P. G., & Harrison, L. C. (2008) · Diabetes Care · doi:10.2337/dc08-0239 · Cited by 228
Self-citationIncidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden
Thunander, M., Petersson, C., Jonzon, K., Fornander, J., Ossiansson, B., Torn, C., Edvardsson, S., & Landin-Olsson, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.07.022 · Cited by 218
Type 1 Diabetes and Latent Autoimmune Diabetes in Adults: One End of the Rainbow
Leslie, R. D. G., Williams, R., & Pozzilli, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1623 · Cited by 142
Diabetes classification: grey zones, sound and smoke: Action LADA 1
Leslie, R. D. G., Kolb, H., Schloot, N. C., Buzzetti, R., Mauricio, D., De Leiva, A., Yderstraede, K., Sarti, C., Thivolet, C., Hadden, D., et al. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.877 · Cited by 136
“LADA, taken as an entity, is clearly distinct from type 2 diabetes but not entirely from KPD; that distinction is demographic (LADA patients tend to be younger and less obese), clinical (metabolic syndrome is less frequent), genetic (LADA is HLA-associated), immunological (LADA patients have autoantibodies and T-cell…”
BackgroundLatent autoimmune diabetes in adults: a guide for the perplexed
Gale, E. A. M. (2005) · Diabetologia · doi:10.1007/s00125-005-1954-5 · Cited by 135
“might escape from some of these limitations [1].”
BackgroundInfluentialMaddaloni, E., Lessan, N., Al Tikriti, A., Buzzetti, R., Pozzilli, P., & Barakat, M. T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131837 · Cited by 93
Carlsson, S., Midthjell, K., & Grill, V. (2007) · Diabetes Care · doi:10.2337/dc07-0718 · Cited by 63
“L atent autoimmune diabetes of the adult (LADA) is a common form of diabetes, but the risk factors, including the impact of family history of diabetes (FHD), are less well understood than those for type 1 and type 2 diabetes (1).”
BackgroundThe epidemiology of type 1 diabetes mellitus in older adults
Tomic, D., Harding, J. L., Jenkins, A. J., Shaw, J. E., & Magliano, D. J. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01046-z · Cited by 58
“In 2005, the Immunology of Diabetes Society proposed the following criteria for LADA to standardize the diagnosis: age of onset >30 years; presence of any islet autoantibodies and a minimum of 6 months without requirement for exogenous insulin 75 .”
Murao, S., Kondo, S., Ohashi, J., Fujii, Y., Shimizu, I., Fujiyama, M., Ohno, K., Takada, Y., Nakai, K., Yamane, Y., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.024 · Cited by 57
Characteristics and Prevalence of Latent Autoimmune Diabetes in Adults (LADA)
Brahmkshatriya, P. P., Mehta, A. A., Saboo, B. D., & Goyal, R. K. (2012) · ISRN Pharmacology · doi:10.5402/2012/580202 · Cited by 54
Past, present and future of latent autoimmune diabetes in adults
Liu, B., Xiang, Y., Liu, Z., & Zhou, Z. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3205 · Cited by 50
Screening for associated autoimmune disorders in Polish patients with Addison’s disease
Fichna, M., Fichna, P., Gryczyńska, M., Walkowiak, J., Żurawek, M., & Sowiński, J. (2010) · Endocrine · doi:10.1007/s12020-010-9312-x · Cited by 47
Xiang, Y., Huang, G., Shan, Z., Pan, L., Luo, S., Yang, L., Shi, L., Li, Q., Leslie, R. D., & Zhou, Z. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0799-8 · Cited by 42
Zhu, Y., Qian, L., Liu, Q., Zou, J., Zhou, Y., Yang, T., Huang, G., Zhou, Z., & Liu, Y. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0007 · Cited by 26
Metadata
- Authors
- Fourlanos, S., Dotta, F., Greenbaum, C. J., Palmer, J. P., Rolandsson, O., Colman, P. G., & Harrison, L. C.
- Venue
- Diabetologia
- Published
- 2005-09-29
- Volume
- 48
- Issue
- 11
- Pages
- 2206-2212
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1967314259
- Cited by
- 401
- References
- 58
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.